F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval July 9, 2021 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Food and Drug Administration, Woodcock, Janet 0 The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.